Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook
Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook
Plus Therapeutics GAAP EPS of -$1.31 misses by $0.45; reaffirms FY outlook
Login to unlock74characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.